Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 6 | 2017 | 272 | 0.910 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 8 | 0.720 |
Why?
|
| Pain | 2 | 2016 | 24 | 0.720 |
Why?
|
| Vulnerable Populations | 2 | 2015 | 31 | 0.610 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2016 | 7 | 0.590 |
Why?
|
| Pain Management | 1 | 2016 | 11 | 0.590 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 16 | 0.590 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 35 | 0.580 |
Why?
|
| Hip Fractures | 1 | 2016 | 3 | 0.570 |
Why?
|
| Managed Care Programs | 1 | 2016 | 6 | 0.570 |
Why?
|
| Length of Stay | 1 | 2016 | 16 | 0.560 |
Why?
|
| Aged | 10 | 2017 | 607 | 0.560 |
Why?
|
| Male | 11 | 2017 | 1649 | 0.490 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 28 | 0.490 |
Why?
|
| Female | 11 | 2017 | 1733 | 0.470 |
Why?
|
| Hypertension | 1 | 2014 | 56 | 0.470 |
Why?
|
| Humans | 12 | 2017 | 2493 | 0.440 |
Why?
|
| Los Angeles | 5 | 2016 | 210 | 0.370 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 246 | 0.340 |
Why?
|
| Spinal Neoplasms | 2 | 2017 | 3 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 64 | 0.270 |
Why?
|
| Middle Aged | 5 | 2017 | 799 | 0.230 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 12 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 27 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2017 | 1 | 0.160 |
Why?
|
| Medication Adherence | 1 | 2017 | 13 | 0.160 |
Why?
|
| Health Literacy | 1 | 2017 | 13 | 0.160 |
Why?
|
| Sarcoma, Ewing | 1 | 2016 | 1 | 0.150 |
Why?
|
| Health Services Misuse | 1 | 2016 | 4 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 116 | 0.150 |
Why?
|
| Pain Measurement | 1 | 2016 | 39 | 0.150 |
Why?
|
| Drug Interactions | 1 | 2016 | 18 | 0.150 |
Why?
|
| Industry | 1 | 2016 | 1 | 0.150 |
Why?
|
| Motion Pictures | 1 | 2016 | 1 | 0.150 |
Why?
|
| Occupational Injuries | 1 | 2016 | 1 | 0.150 |
Why?
|
| Comorbidity | 1 | 2016 | 54 | 0.150 |
Why?
|
| Musculoskeletal System | 1 | 2016 | 3 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 61 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2016 | 10 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2016 | 10 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2016 | 42 | 0.140 |
Why?
|
| Prospective Studies | 1 | 2016 | 121 | 0.140 |
Why?
|
| Independent Living | 1 | 2015 | 6 | 0.140 |
Why?
|
| Adult | 5 | 2017 | 807 | 0.130 |
Why?
|
| Diuretics | 1 | 2014 | 4 | 0.120 |
Why?
|
| Perception | 1 | 2014 | 13 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2014 | 10 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 30 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 9 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 35 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2014 | 24 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 14 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2014 | 55 | 0.120 |
Why?
|
| Acetabulum | 1 | 2013 | 1 | 0.120 |
Why?
|
| Osteophyte | 1 | 2013 | 1 | 0.120 |
Why?
|
| Osteoarthritis, Hip | 1 | 2013 | 3 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2013 | 4 | 0.120 |
Why?
|
| Neoplasms | 1 | 2014 | 54 | 0.120 |
Why?
|
| Rhinoplasty | 1 | 2011 | 1 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 1 | 0.100 |
Why?
|
| Epinephrine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 267 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 36 | 0.100 |
Why?
|
| Young Adult | 3 | 2016 | 175 | 0.090 |
Why?
|
| Adolescent | 3 | 2016 | 305 | 0.090 |
Why?
|
| SEER Program | 2 | 2017 | 3 | 0.080 |
Why?
|
| Prognosis | 2 | 2017 | 47 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2017 | 210 | 0.060 |
Why?
|
| Risk Factors | 2 | 2015 | 240 | 0.060 |
Why?
|
| Prescription Drugs | 1 | 2017 | 5 | 0.040 |
Why?
|
| Potentially Inappropriate Medication List | 1 | 2017 | 5 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2017 | 10 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 10 | 0.040 |
Why?
|
| Hospitalization | 1 | 2017 | 40 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 31 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2016 | 28 | 0.040 |
Why?
|
| Workers' Compensation | 1 | 2016 | 1 | 0.040 |
Why?
|
| Risk | 1 | 2016 | 19 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2016 | 23 | 0.040 |
Why?
|
| California | 1 | 2016 | 93 | 0.040 |
Why?
|
| United States | 1 | 2017 | 324 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 27 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 35 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 25 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 46 | 0.030 |
Why?
|
| Health Behavior | 1 | 2014 | 37 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 32 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hip Prosthesis | 1 | 2013 | 3 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 16 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 119 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 1 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2011 | 28 | 0.030 |
Why?
|
| Time Factors | 1 | 2011 | 120 | 0.020 |
Why?
|